Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 3, 2001

View Archived Issues

Gene Causing Cleft Palate Traced In Icelandic Families

CeNeS Cuts Staff, Programs In Move To Conserve Money

Cellzome Strengthens Discovery Capability Via Cell Map Purchase

RiboTargets Raises #32M In Third Financing Round

Peplin Identifies, Patents Role Of PKC In Several Conditions

Other News To Note

Neurotech Validates Human Cell-Based Work In Eye Disease

Nanotechnology Opens Doors To Investigation Of Single Cells

EU Officials Continue Shaping Issues, But Reach No Decisions

French Advisory Body Suggests Increased Trials Of GM Crops

Isogenica Licenses Affitech Display Library Technology

PhotoCure Submits NDA For Actinic Keratosis Product

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.